Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
myopia
MedTech
Alcon sees Staar Surgical for $1.5B deal
Alcon plans to pay a premium of 59% over Staar’s average stock price, as the company deals with declining revenues.
Conor Hale
Aug 5, 2025 11:00am
J&J nets new FDA approval for nearsightedness-fighting contacts
Sep 29, 2022 11:59am
Staar Surgical scopes out FDA OK for vision-correcting implant
Mar 29, 2022 10:40am
J&J tackles childhood myopia with new FDA contact lens clearance
May 12, 2021 12:32pm
J&J Vision taps Menicon in battle against myopia progression
Apr 7, 2021 11:08am
Study shows multifocal contacts can slow down childhood myopia
Aug 14, 2020 3:02pm
